These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8718793)

  • 21. Expression of cytokeratins and additional markers in undifferentiated lymph node metastases of the neck.
    Bartel-Friedrich S; Friedrich RE; Holzhausen HJ
    Anticancer Res; 2000; 20(6D):4931-40. PubMed ID: 11326642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine differentiation in non-small cell lung carcinomas.
    Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
    In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of cytoskeletal proteins in small cell lung carcinoma.
    Hlozánková M; Lukás Z; Viklický V
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():47-9. PubMed ID: 10707834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
    Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
    Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
    Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
    Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New diagnostic method in pulmonary carcinoid].
    Csiszér E; Antus B; Himber G; Hertel K; Fillinger J
    Magy Onkol; 2007; 51(3):225-8. PubMed ID: 17922062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index.
    Horn LC; Hentschel B; Bilek K; Richter CE; Einenkel J; Leo C
    Ann Diagn Pathol; 2006 Jun; 10(3):140-3. PubMed ID: 16730307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistology of neuroendocrine and neuroectodermal tumors.
    Wick MR
    Semin Diagn Pathol; 2000 Aug; 17(3):194-203. PubMed ID: 10968705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients.
    Rugge M; Fassan M; Clemente R; Rizzardi G; Giacomelli L; Pennelli G; Mescoli C; Segat D; Rea F
    Clin Cancer Res; 2008 Jan; 14(1):149-54. PubMed ID: 18172265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical presentation and evaluation of neuroendocrine tumors of the lung.
    Detterbeck FC
    Thorac Surg Clin; 2014 Aug; 24(3):267-76. PubMed ID: 25065927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
    Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
    Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
    Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
    J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carcinoid tumor of the middle ear. Morphology, immunohistochemistry, clinical aspects and differential diagnosis].
    Ruck P; Pfisterer EM; Kaiserling E
    Laryngorhinootologie; 1990 Feb; 69(2):74-6. PubMed ID: 2322359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical evaluation of neuroendocrine cells and neoplasms of the lung.
    Gould VE; Lee I; Warren WH
    Pathol Res Pract; 1988 Apr; 183(2):200-13. PubMed ID: 3290868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor markers--personal experience. Immunohistochemical markers for cancer diagnosis].
    Mukai K
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1383-8. PubMed ID: 2069409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The cytologic diagnosis of rare lung tumors (author's transl)].
    Jaugitz H; Zimmer S
    Z Erkr Atmungsorgane; 1975 Jun; 143(3):277-88. PubMed ID: 1226901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of determining the levels of bombesin and gamma-enolase in differential diagnosis of bronchogenic carcinoma of the lung].
    Krzyzanowska-Rewińska H
    Patol Pol; 1990; 41(1-2):38-42. PubMed ID: 2100790
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pneumological oncology--diagnosis].
    Prax Klin Pneumol; 1985 Dec; 39 Suppl 1():805-31. PubMed ID: 4095086
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic criteria of classical carcinoids.
    Wilander E; Scheibenpflug L; Eriksson B; Oberg K
    Acta Oncol; 1991; 30(4):469-75. PubMed ID: 1854504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.